Cannabidiols (CBD) prohibited
US Equestrian warns horse owners that CBD positives will result in equine drug violations this fall.
So, just say NEIGH!
That’s because USEF Equine Drugs and Medications Rules prohibit cannabidiols (CBD) and their metabolites.
So, why is the Federation making the announcement now?
It comes after the 2018 Farm Bill legalized hemp and declassified it as a Schedule I controlled substance. The definition includes hemp that doesn’t contain more than 0.3% THC and plants that produce cannabidiol oil (CBD).
According to US Equestrian, both natural and synthetic CBD, “are likely to affect horse performance” due to its reported anti-anxiety effects. Additionally, the press release adds that the substance is no different than other legitimate therapeutics that affect behavior in horses, although it provides no support of the claim.
As of September 1, 2019, horses competing under USEF rules that test positive for natural cannabinoids, synthetic cannabinoids, and other cannabimimetics are in violation of GR4. The FEI also includes the group as prohibited substances.
CBD detections prior to that date will receive warnings. They will be considered a “Prior” violation if there are additional detections of cannabinoids following September 1.
Additionally, GR411 Conditions For Therapeutic Administrations of Prohibited Substances don’t apply for cannabinoids, so there’s no medication reporting form.
US Equestrian notes that analytical methods are being implemented to detect CBD and similar cannabinoids.
Equestrians subject to testing under the World Anti-Doping Code should view the athlete regulations pertaining to cannabinoids here.